Phar 7.03 Drug utilization review.
Phar 7.04 Transferring prescription order information.
Phar 7.05 Label requirements.
Phar 7.06 Repackaging for stock.
Phar 7.08 Patient consultation.
Phar 7.085 Delivery by common carrier or delivery services.
Phar 7.09 Procurement, recall and out-of-date drugs and devices.
Phar 7.10 Return or exchange of health items.
Phar 7.11 Pharmacy records.
Phar 7.12 Delegation by a physician.
Phar 7.13 Administration of drug products and devices other than vaccines.
Phar 7.14 Pharmacy product verification technician-check-pharmacy technician.
Phar 7.15 Consumer disclosures.
Subchapter II — Central Shared Services
Subchapter III — Delivery Systems and Remote Dispensing
Phar 7.41 Delivery system.
Phar 7.42 Automated direct-to-patient dispensing system.
Phar 7.43 Remote dispensing.
Subchapter IV — Institutional Pharmacies
Phar 7.53 Security and access.
Phar 7.54 Return or exchange of health items.
Phar 7.55 Automated technology product verification.
Subchapter V — Uncredentialed Pharmacy Staff
Phar 7.62 Uncredentialed pharmacy staff.
Ch. Phar 7 Note
Note: Chapter Phar 7 as it existed on December 31, 2020, was repealed and a new chapter Phar 7 was created, effective January 1, 2021.
Phar 7.01
Phar 7.01
Definitions. In this chapter:
Phar 7.01(1)
(1) “
Control number” means a unique number used to identify a repackaged drug or drug product in reference to a record that contains NDC, expiration date, and lot number.
Phar 7.01(2)
(2) “
Managing pharmacist” means a pharmacist who accepts responsibility for the operation of a pharmacy in conformance with all laws and rules pertinent to the practice of pharmacy, and who is personally in full and actual charge of the pharmacy and personnel.
Phar 7.01(4)
(4) “
Repackaging for stock” means transferring a non-sterile drug product from the stock container in which it was distributed by the original manufacturer and placing it into a different stock container as a source for subsequent prescription dispensing without further manipulation of the drug.
Phar 7.01(5)
(5) “
Standing order” means an order transmitted electronically or in writing by a practitioner for a drug or device that does not identify a particular patient at the time it is issued for the purpose of drug or device dispensing or administration to individuals that meet criteria of the order.
Phar 7.01 History
History: CR 19-145: cr.
Register December 2020 No. 780, eff. 1-1-21.
Phar 7.02(1)(1)
Requirements. A prescription drug order shall include all of the following:
Phar 7.02(1)(c)
(c) Prescriptions ordered by a delegate of the practitioner shall include the first and last name of the delegate and the first and last name and address of the practitioner.
Phar 7.02(1)(d)
(d) Name, strength, and quantity of the drug product or device.
Phar 7.02(1)(g)
(g) Symptom or purpose for which the drug is being prescribed if the patient indicates in writing to the practitioner that the patient wants the symptom or purpose for the prescription to be disclosed on the label.
Phar 7.02(1)(j)
(j) If prescription is issued under s.
255.07 (2), Stats., the name and address of the authorized entity or individual.
Phar 7.02(1)(k)
(k) Practitioner's written signature, or electronic or digital signature.
Phar 7.02(2)(a)(a) A prescription pursuant to a standing order shall include all of the following:
Phar 7.02(2)(a)3.
3. Prescriptions ordered by a delegate of the practitioner shall include the first and last name of the delegate and the first and last name and address of the practitioner.
Phar 7.02(2)(a)9.
9. If prescription is issued under s.
255.07 (2), Stats., the name and address of the authorized entity or individual.
Phar 7.02(2)(a)10.
10. An indication that the prescription is pursuant to a standing order.
Phar 7.02(3)(a)
(a) Except as provided in s.
89.068 (1) (c) 4., Stats., and as otherwise prohibited by law, a practitioner may transmit a prescription order electronically only if the patient approves the transmission and the prescription order is transmitted to a pharmacy designated by the patient. Prescription orders transmitted by facsimile machine are not considered electronic prescription orders; but rather, written prescription orders.
Phar 7.02(3)(b)
(b) The prescribing practitioner's electronic signature, or other secure method of validation shall be provided electronically with a prescription order.
Phar 7.02(4)
(4) Verbal prescription. Verbal prescription orders may be received at a pharmacy via a direct conversation, telephone answering device or voice mail. The verbal prescription shall be reduced to writing or entered into a computer system under s.
Phar 7.11 (2) and the prescription record shall indicate the pharmacist responsible for the accuracy of the prescription information.
Phar 7.02(5)
(5)
Alterations. Any alterations that modify the original intent of a prescription shall be documented including the identification of the pharmacist responsible for the alteration and the practitioner or practitioner's delegate who authorized the alteration.
Phar 7.02 History
History: CR 19-145: cr.
Register December 2020 No. 780, eff. 1-1-21; correction in (1) (j), (2) (a) 9., 10. made under s.
35.17, Stats.,
Register December 2020 No. 780.
Phar 7.03(1)(1)
A pharmacist shall complete a drug utilization review by reviewing the patient record prior to dispensing each prescription drug order for all of the following:
Phar 7.03(1)(d)
(d) Reasonable dose, duration of use, and route of administration, considering the age and other patient factors.
Phar 7.03(1)(g)
(g) Drug interactions with food, beverages, other drugs or medical conditions.
Phar 7.03(1)(i)
(i) Reasonable utilization and optimum therapeutic outcomes.
Phar 7.03(2)
(2) Upon recognizing a concern with any of the items in sub.
(1) (a) to
(j), the pharmacist shall take steps to mitigate or resolve the problem.
